Icure Pharmaceutical (XKRX:175250) Short-Term Capital Lease Obligation : ₩1,169 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Icure Pharmaceutical Short-Term Capital Lease Obligation?

Icure Pharmaceutical's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₩1,169 Mil.

Icure Pharmaceutical's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 (₩1,249 Mil) to Dec. 2024 (₩1,234 Mil) and declined from Dec. 2024 (₩1,234 Mil) to Mar. 2025 (₩1,169 Mil).

Icure Pharmaceutical's annual Short-Term Capital Lease Obligation declined from Dec. 2022 (₩171 Mil) to Dec. 2023 (₩78 Mil) but then increased from Dec. 2023 (₩78 Mil) to Dec. 2024 (₩1,234 Mil).

Icure Pharmaceutical Short-Term Capital Lease Obligation Historical Data

The historical data trend for Icure Pharmaceutical's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icure Pharmaceutical Short-Term Capital Lease Obligation Chart

Icure Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

147.81

185.44

171.09

77.56

1,233.94

Icure Pharmaceutical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															61.67	49.16	1,249.33	1,233.94	1,168.88

Icure Pharmaceutical Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Icure Pharmaceutical Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Icure Pharmaceutical's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Icure Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Icure Pharmaceutical Inc (XKRX:175250) » Definitions » Short-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

7, Saimdang-ro 1-gil, Seocho-gu, Seoul, KOR

Website

https://www.icure.co.kr

Icure Pharmaceutical Inc operates as a biopharmaceutical company engages in the development and commercialization of novel transdermal drug delivery formulation. It also developed and commercialized various patches and hydrogels for the treatment of rheumatic arthritis pain, nicotine replacement therapy, medicated wound dressings, skin care, and dental care. The products pipeline is also aimed at the development of prescription drugs to diseases of the central nervous system, asthma, and pain.

Icure Pharmaceutical Headlines

No Headlines